Nalaganje...
Phase I/II study of the combination of panobinostat and carfilzomib in patients with relapsed/refractory multiple myeloma
The purpose of this study was to assess the safety and efficacy of the combination of panobinostat and carfilzomib in patients with relapsed/refractory multiple myeloma. Patients with multiple myeloma who had relapsed after at least one prior treatment were eligible to participate. In the dose escal...
Shranjeno v:
| izdano v: | Haematologica |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Ferrata Storti Foundation
2015
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4420216/ https://ncbi.nlm.nih.gov/pubmed/25710456 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2014.119735 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|